Triple

T36599359
Position Surface form Disambiguated ID Type / Status
Subject lapatinib E902877 entity
Predicate instanceOf P0 FINISHED
Object oral anticancer agent C46685 CONCEPT FINISHED

How this triple was built (1 step)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

CD Concept disambiguation gpt-5-mini-2025-08-07
Target class: oral anticancer agent
Context triple: [lapatinib, instanceOf, oral anticancer agent]
  • A. anti‑cancer drug
    An anti-cancer drug is a pharmacological agent designed to prevent, inhibit, or eliminate the growth and spread of malignant cells in the body.
  • B. antineoplastic immunomodulating agent
    An antineoplastic immunomodulating agent is a drug that treats cancer by modifying or enhancing the body’s immune response to recognize and destroy malignant cells.
  • C. cancer drug chosen
    A cancer drug is a therapeutic agent specifically designed to prevent, slow, or eliminate the growth and spread of cancer cells in the body.
  • D. antimetabolite
    An antimetabolite is a drug that mimics natural cellular metabolites to interfere with DNA or RNA synthesis, thereby inhibiting cell growth and division, commonly used in cancer and autoimmune disease treatment.
  • E. oral nutritional supplement
    An oral nutritional supplement is a formulated product consumed by mouth to provide additional calories, protein, vitamins, minerals, and other nutrients to support or enhance a person’s dietary intake.
  • F. None of above.

Provenance (1 batch)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69f76e66b7b88190848f7a3e1188915f completed May 3, 2026, 3:48 p.m.
Created at: May 3, 2026, 4:11 p.m.